The Dynamics of Cardiovascular Risk—An Analysis of the Prospective Urban Rural Epidemiology (PURE) Poland Cohort Study

Author:

Lubieniecki Paweł1ORCID,Lewandowski Łukasz2ORCID,Wołyniec Maria3,Połtyn-Zaradna Katarzyna3,Zatońska Katarzyna34ORCID,Szuba Andrzej5

Affiliation:

1. Clinical Department of Diabetology and Internal Disease, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland

2. Department of Medical Biochemistry, Wroclaw Medical University, Chalubinskiego 10, 50-368 Wroclaw, Poland

3. Population Health Department, Wroclaw Medical University, 50-345 Wrocław, Poland

4. Calisia University, 62-800 Kalisz, Poland

5. Clinical Department of Angiology and Internal Disease, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland

Abstract

Background: The purpose of this study was to analyze the major cardiovascular risk (CVR) factors and their trends in the study population. Methods: The results of subjects in the Polish Prospective Urban and Rural Epidemiological Study (PURE) study group were interpreted. CVR was calculated for each participant according to the Systematic Coronary Risk Evaluation (SCORE2) scale or the Systematic Coronary Risk Evaluation–Older Persons (SCORE2–OP) scale. Data from the beginning of the analysis (2013) and nine years later (2022) were included. In addition, the use of lipid–lowering therapy (LLT) and meeting the low–density lipoprotein cholesterol (LDL–c) target criterion at the beginning and end of the study were analyzed. Results: Patients in the high and very high CVR groups who had abnormal LDL–c results accounted for 64% and 91% of their group in 2013 and 70% and 92% in 2022, respectively. Conclusions: Regardless of age, patients using LLT at the start of the analysis had a greater increase in future CVR, especially if they had lipid abnormalities at the start of the study. This may be due to reverse causality and multimorbidity in these patients, highlighting the importance of appropriate treatment of lipid abnormalities.

Funder

Polish Ministry of Science and Higher Education

Medical University of Wroclaw

Publisher

MDPI AG

Reference36 articles.

1. Di Cesare, M., Bixby, H., Gaziano, T., Hadeed, L., Kabudula, C., Vaca McGhie, D., Mwangi, J., Pervan, B., Perel, P., and Piñeiro, D. (2023). World Heart Report 2023: Confronting the World’s Number One Killer, World Heart Federation.

2. National Health Fund of Poland (2024, June 12). RAPORT NFZ: Nadciśnienie Tętnicze, Poland Government, Available online: https://www.nfz.gov.pl/aktualnosci/aktualnosci-centrali/raport-nfz-nadcisnienie-tetnicze,7352.html.

3. Changes in the prevalence, treatment, and control of hypercholesterolemia and other dyslipidemias over 10 years in Poland: The WOBASZ study;Szafraniec;Pol. Arch. Med. Wewn.,2016

4. Analiza stanu wiedzy o czynnikach ryzyka chorób układu sercowo-naczyniowego wśród osób pracujących;Nowicki;Nurs. Top.,2009

5. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice;Visseren;Eur. Heart J.,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3